Invasive lobular carcinoma (ILC) is the most common of the breast cancer special types,
accounting for up to 15% of all breast cancer cases. ILCs are noted for their lack of E …

Background Invasive lobular breast cancer (ILC) is the second most common type of breast
cancer after invasive breast cancer of no special type (NST), representing up to 15% of all …

Invasive lobular carcinoma (ILC) is the second most common type of invasive breast cancer
after invasive ductal carcinoma (IDC). Invasive lobular carcinoma has unique clinical …

Breast cancer is the most prevalent malignant tumor and main oncologic cause of mortality
in women. Although most diagnosis of breast pathology is accomplished using hematoxylin …

Background There is increasing interest in better understanding the biology and clinical
presentation of invasive lobular cancer (ILC), which is the most common special histological …

Invasive lobular carcinoma (ILC) is the second most common histological subtype of breast
cancer following invasive ductal carcinoma (IDC). ILC differs from IDC in a number of …

Background Invasive lobular carcinoma (ILC) as a disease entity distinct from invasive
ductal carcinoma (IDC) has merited focused studies of the genomic landscape, but those to …

Abstract Invasive lobular carcinoma comprises 10–15% of all breast cancers and is
increasingly recognised as a distinct and understudied disease compared with the …

Importance The disparate prognostic implications between invasive ductal carcinoma (IDC)
and invasive lobular carcinoma (ILC) have been demonstrated. However, information on …

This study describes “lobular-like invasive mammary carcinomas”(LLIMCas), a group of low-
to intermediate-grade invasive mammary carcinomas with discohesive, diffusely infiltrative …